<?xml version="1.0" encoding="UTF-8"?>
<results title="instrument">
 <result pre="with naloxone inhibited EOZC-induced antinociception activity (P&amp;lt;0.05). Based on the" exact="GC-MS" post="results, EOZC comprised 65.22% carvacrol, 19.51% thymol, 4.86% p-cymene"/>
 <result pre="(Thermo Quest Finningan, UK), as presented in Table 1. The" exact="GC-MS" post="instrument was 5% phenyl methyl silicone and 95% dimethylpolysiloxane"/>
 <result pre="injector was 250Â°C. To improve accuracy of the results, the" exact="GC-MS" post="analysis was performed in triplicate. Table 1. The chemical"/>
 <result pre="by both peripheral and central antinociceptive mechanisms. Based on the" exact="GC-MS" post="results, EOZC contained high concentrations of phenolic compounds including"/>
</results>
